Oncology

Your Article Summary

See Latest Articles

RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation
Virchows Archiv, 06/09/09

Nakazawa T et al. - In a study to examine the prevalence of RET/PTC and its impact on cancer progression, even though RET/PTC is a specific genetic event in carcinomas, it was shown that RET/PTCs occur in a small population of tumor cells in papillary thyroid carcinomas. The results suggested the possibility of RET/PTC as “passenger” abnormalities rather than “driver” oncogenic mutation during thyroid cancer progression.

• Interphase fluorescence in situ hybridization (FISH) was applied to touch imprint cytology of 14 papillary thyroid carcinomas along with reverse-transcription polymerase chain reaction (RT-PCR) analysis.
• FISH DNA probes included RET locus, and PCR primers were designed targeting RET/PTC1 or RET/PTC3.

• Split FISH signals of RET were observed in 78.6% (11/14) of tumors.
• Proportions of tumor cells having split RET signals ranged from 1.8% to 19.6% in those 11 tumors.
• In RT-PCR analysis, RET/PTC was found in 28.6% (4/14) of tumors.
• Among tumors with split RET signals, 36.4% (4/11) of tumors exhibited detectable messenger RNA of RET/PTC1 or RET/PTC3.
• The remaining 7 tumors with split RET signals had no RET/PTCs amplicon.

Today in Endocrine Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09

Thyroid lymphoma and airway obstruction – is there a rationale for surgical management?
International Journal of Clinical Practice, 10/19/09

Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09

See All of Endocrine Oncology